Tempus AI (NASDAQ:TEM) Trading 6.1% Higher – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares traded up 6.1% during mid-day trading on Thursday . The company traded as high as $81.25 and last traded at $81.2690. Approximately 8,574,459 shares changed hands during mid-day trading, an increase of 40% from the average session volume of 6,142,033 shares. The stock had previously closed at $76.59.

Wall Street Analyst Weigh In

TEM has been the subject of several recent analyst reports. Needham & Company LLC restated a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a research report on Friday, July 31st. Wolfe Research began coverage on shares of Tempus AI in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Guggenheim upped their price objective on Tempus AI from $60.00 to $65.00 and gave the company a “buy” rating in a report on Thursday, July 16th. Stifel Nicolaus lowered their price objective on Tempus AI from $60.00 to $50.00 and set a “hold” rating for the company in a research report on Monday, August 3rd. Finally, Lake Street Capital cut Tempus AI to a “hold” rating in a research note on Monday, July 20th. Eleven equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Tempus AI currently has an average rating of “Hold” and an average price target of $69.63.

Tempus AI Stock Performance

The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06. The stock has a market capitalization of $14.65 billion, a price-to-earnings ratio of -56.62 and a beta of 3.72. The firm’s fifty day moving average price is $58.39 and its 200 day moving average price is $53.43.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to analysts’ expectations of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The firm’s revenue was up 21.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.22) earnings per share. Analysts forecast that Tempus AI, Inc. will post -1.38 EPS for the current fiscal year.

Insider Activity

In other Tempus AI news, CEO Ryan Fukushima sold 700 shares of the stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $70.00, for a total value of $49,000.00. Following the sale, the chief executive officer directly owned 15,874 shares of the company’s stock, valued at approximately $1,111,180. This represents a 4.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Andrew Polovin sold 2,951 shares of the stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $75.00, for a total value of $221,325.00. Following the completion of the transaction, the executive vice president directly owned 135,189 shares in the company, valued at $10,139,175. This trade represents a 2.14% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 1,240,499 shares of company stock valued at $73,096,282. 24.26% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Tempus AI

Hedge funds and other institutional investors have recently made changes to their positions in the business. QRG Capital Management Inc. purchased a new stake in Tempus AI during the second quarter worth approximately $240,000. WINTON GROUP Ltd acquired a new stake in Tempus AI during the second quarter worth approximately $342,000. Engineers Gate Manager LP acquired a new stake in Tempus AI during the second quarter worth approximately $637,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Tempus AI during the 2nd quarter worth approximately $145,000. Finally, Baird Financial Group Inc. boosted its holdings in shares of Tempus AI by 3.4% in the 2nd quarter. Baird Financial Group Inc. now owns 30,434 shares of the company’s stock valued at $1,763,000 after buying an additional 994 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI, Inc is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies.

Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management.

The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States.